Company Filing History:
Years Active: 2003-2006
Title: Michaela Scherr: Innovator in RNA Research
Introduction
Michaela Scherr is a prominent inventor based in Oberusel, Germany. She has made significant contributions to the field of RNA research, particularly in identifying accessible binding sites on RNA. With a total of 2 patents, her work has the potential to advance therapeutic approaches in molecular biology.
Latest Patents
Michaela Scherr's latest patents include a method for identifying accessible binding sites on RNA. This innovative method involves incubating native or in vitro-synthesized target RNA with defined oligonucleotides (ODNs) and RNase H, or with a random or semi-random ODN library and RNase H. The process can also utilize defined ribozymes or DNAzymes, or a semi-random ribozyme or DNAzyme library, in a cell extract containing endogenous RNA-binding proteins. The method allows for the identification of sites on target RNA that are accessible for pairing by antisense DNA, ribozymes, or DNAzymes, leading to RNA cleavage at those sites.
Career Highlights
Michaela Scherr is currently associated with City of Hope, where she continues her research and development in RNA technologies. Her work has garnered attention for its innovative approach to understanding RNA interactions and their implications in various biological processes.
Collaborations
Michaela has collaborated with notable scientists in her field, including John J. Rossi and Arthur D. Riggs. These collaborations have further enriched her research and contributed to advancements in RNA studies.
Conclusion
Michaela Scherr is a trailblazer in RNA research, with her innovative methods paving the way for future discoveries in molecular biology. Her contributions are invaluable to the scientific community and hold promise for therapeutic advancements.